Skip to content
777 Sourcing.

Capability

in vitro and in vivo studies

Suppliers
2
States & provinces
2
Countries
1

2 in vitro and in vivo studies suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

AUSTRALIS PHARMACEUTICALS INC

FRANKLIN, TN

Australis is a global biopharmaceutical company developing cancer therapies, centered on its lead compound AUS_001, a naturally derived compound discovered in honeybee propolis from Kangaroo Island. Its in-house research is based at a laboratory in Simi Valley, California, staffed by PhD scientists, with third-party research performed worldwide. AUS_001 has shown pre-clinical efficacy against 24 types of cancer and has received FDA Orphan Drug Designation for malignant gliomas and Rare Pediatric Disease Designation for pediatric-type diffuse high-grade g

clinical trial developmentdrug formulationGLP toxicology studiespre-clinical research

Compiled from public sources

DECKTHERAPEUTICS, INC

HASTINGS ON HUDSON, NY

DeckTherapeutics is pioneering the new field of acute omega-3 fatty acid therapeutics. Its proprietary semi-synthetic omega-3 compounds are formulated as emulsions administered intravenously, exerting immediate effect on molecular pathways controlling cellular apoptosis and necrosis. Its lead candidate THDG3, developed at Columbia University, is a neuroprotectant with lead indication neonatal hypoxic-ischemic encephalopathy (HIE), with potential uses in ischemic stroke and other hypoxic-ischemic brain injuries.

intravenous emulsion formulationneuroprotection therapeutics development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list in vitro and in vivo studies.

Browse all capabilities